BLUEPRINT MEDICINES CORPORATION: change in accounts payable

What this measure means

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Exact concept: us-gaap:IncreaseDecreaseInAccountsPayable. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2013-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• BLUEPRINT MEDICINES CORPORATION: total assets
• BLUEPRINT MEDICINES CORPORATION: total liabilities
• BLUEPRINT MEDICINES CORPORATION: stockholders equity
• BLUEPRINT MEDICINES CORPORATION: cash and cash equivalents
• BLUEPRINT MEDICINES CORPORATION: net income or loss
• BLUEPRINT MEDICINES CORPORATION: operating cash flow
• BLUEPRINT MEDICINES CORPORATION: capital expenditure payments
• BLUEPRINT MEDICINES CORPORATION: revenue
• BLUEPRINT MEDICINES CORPORATION: financing cash flow
• BLUEPRINT MEDICINES CORPORATION: investing cash flow
• BLUEPRINT MEDICINES CORPORATION: retained earnings or deficit
• BLUEPRINT MEDICINES CORPORATION: basic weighted-average shares
• BLUEPRINT MEDICINES CORPORATION: diluted weighted-average shares
• BLUEPRINT MEDICINES CORPORATION: basic earnings per share
• BLUEPRINT MEDICINES CORPORATION: diluted earnings per share
• BLUEPRINT MEDICINES CORPORATION: income tax expense or benefit
• BLUEPRINT MEDICINES CORPORATION: net property, plant and equipment
• BLUEPRINT MEDICINES CORPORATION: share-based compensation expense
• BLUEPRINT MEDICINES CORPORATION: current assets
• BLUEPRINT MEDICINES CORPORATION: current liabilities
• BLUEPRINT MEDICINES CORPORATION: current accounts payable
• BLUEPRINT MEDICINES CORPORATION: net current accounts receivable
• BLUEPRINT MEDICINES CORPORATION: operating expenses
• BLUEPRINT MEDICINES CORPORATION: net inventory
• BLUEPRINT MEDICINES CORPORATION: selling, general and administrative expense
• BLUEPRINT MEDICINES CORPORATION: research and development expense
• BLUEPRINT MEDICINES CORPORATION: common shares outstanding
• BLUEPRINT MEDICINES CORPORATION: cash including restricted cash
• BLUEPRINT MEDICINES CORPORATION: additional paid-in capital
• BLUEPRINT MEDICINES CORPORATION: accumulated other comprehensive income or loss
• BLUEPRINT MEDICINES CORPORATION: total equity including noncontrolling interests
• BLUEPRINT MEDICINES CORPORATION: operating lease right-of-use asset
• BLUEPRINT MEDICINES CORPORATION: operating lease liability
• BLUEPRINT MEDICINES CORPORATION: gross property, plant and equipment
• BLUEPRINT MEDICINES CORPORATION: accumulated depreciation on property, plant and equipment
• BLUEPRINT MEDICINES CORPORATION: other noncurrent assets
• BLUEPRINT MEDICINES CORPORATION: other noncurrent liabilities
• BLUEPRINT MEDICINES CORPORATION: accrued current liabilities
• BLUEPRINT MEDICINES CORPORATION: prepaid expenses and other current assets
• BLUEPRINT MEDICINES CORPORATION: current contract liabilities
• BLUEPRINT MEDICINES CORPORATION: pre-tax income or loss from continuing operations
• BLUEPRINT MEDICINES CORPORATION: profit or loss including noncontrolling interests
• BLUEPRINT MEDICINES CORPORATION: comprehensive income or loss
• BLUEPRINT MEDICINES CORPORATION: net income available to common stockholders
• BLUEPRINT MEDICINES CORPORATION: general and administrative expense
• BLUEPRINT MEDICINES CORPORATION: depreciation expense
• BLUEPRINT MEDICINES CORPORATION: depreciation, depletion and amortization
• BLUEPRINT MEDICINES CORPORATION: other nonoperating income or expense
• BLUEPRINT MEDICINES CORPORATION: nonoperating income or expense
• BLUEPRINT MEDICINES CORPORATION: interest paid, net
• BLUEPRINT MEDICINES CORPORATION: income taxes paid, net
• BLUEPRINT MEDICINES CORPORATION: proceeds from issuing common stock
• BLUEPRINT MEDICINES CORPORATION: operating lease payments
• BLUEPRINT MEDICINES CORPORATION: change in accounts receivable
• BLUEPRINT MEDICINES CORPORATION: change in inventories

Inspect the source

Entity

BLUEPRINT MEDICINES CORPORATION / CIK 0001597264

Captured

2026-09-21T17:20:15.396Z

SEC response SHA-256

958cc0ca5a6e3d9924e23c30faf3dde2093699d972b00722326ec324f3342223

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001597264.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))